Hakutulokset - Stephen Johnston

Tarkenna hakua
  1. 1
    Enhancing Endocrine Therapy for Hormone Receptor–Positive Advanced Breast Cancer: Cotargeting Signaling Pathways

    Enhancing Endocrine Therapy for Hormone Receptor–Positive Advanced Breast Cancer: Cotargeting Signaling Pathways Tekijä Stephen Johnston

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    New Strategies in Estrogen Receptor–Positive Breast Cancer

    New Strategies in Estrogen Receptor–Positive Breast Cancer Tekijä Stephen Johnston

    Julkaistu 2010
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer

    Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer Tekijä Mark D. Pegram, Christian Jackisch, Stephen Johnston

    Julkaistu 2023
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    COVID-19 confessions: a qualitative exploration of healthcare workers experiences of working with COVID-19

    COVID-19 confessions: a qualitative exploration of healthcare workers experiences of working with COVID-19 Tekijä Paul Bennett, Simon Noble, Stephen Johnston, David Jones, Rachael Hunter

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation

    Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation Tekijä Lesley‐Ann Martin, Ian Farmer, Stephen Johnston, Simak Ali, Mitch Dowsett

    Julkaistu 2005
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Lapatinib plus Letrozole as First-Line Therapy for HER-2+ Hormone Receptor–Positive Metastatic Breast Cancer

    Lapatinib plus Letrozole as First-Line Therapy for HER-2+ Hormone Receptor–Positive Metastatic Breast Cancer Tekijä Lee S. Schwartzberg, Sandra Franco, Allison Florance, Lisa O’Rourke, Julie Maltzman, Stephen Johnston

    Julkaistu 2010
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Enhanced Estrogen Receptor (ER) α, ERBB2, and MAPK Signal Transduction Pathways Operate during the Adaptation of MCF-7 Cells to Long Term Estrogen Deprivation

    Enhanced Estrogen Receptor (ER) α, ERBB2, and MAPK Signal Transduction Pathways Operate during the Adaptation of MCF-7 Cells to Long Term Estrogen Deprivation Tekijä Lesley‐Ann Martin, Ian Farmer, Stephen Johnston, Simak Ali, Chris Marshall, Mitch Dowsett

    Julkaistu 2003
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Platinum-based chemotherapy in triple-negative breast cancer

    Platinum-based chemotherapy in triple-negative breast cancer Tekijä Bhawna Sirohi, Mónica Arnedos, Sanjay Popat, S. Ashley, Ashutosh Nerurkar, G. Walsh, Stephen Johnston, Ian E. Smith

    Julkaistu 2008
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Lapatinib Restores Hormone Sensitivity with Differential Effects on Estrogen Receptor Signaling in Cell Models of Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer with Acquired Endocrine Resistance

    Lapatinib Restores Hormone Sensitivity with Differential Effects on Estrogen Receptor Signaling in Cell Models of Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer wi... Tekijä Alexandra Léary, Suzanne Drury, Simone Detre, Sunil Pancholi, Anne E. Lykkesfeldt, Lesley‐Ann Martin, Mitch Dowsett, Stephen Johnston

    Julkaistu 2010
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2

    ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2 Tekijä Sunil Pancholi, AE Lykkesfeldt, Caroline Hilmi, Susana Banerjee, Alexandra Léary, Suzanne Drury, Stephen Johnston, Mitch Dowsett, Lesley‐Ann Martin

    Julkaistu 2008
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors: existing and emerging differences

    Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors: existing and emerging differences Tekijä Stephen Johnston, Anna Emde, Carlos H. Barrios, Stefanie Srock, Patrick Neven, M Navarro, David Cameron, Wolfgang Janni, Michael Gnant

    Julkaistu 2023
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases – the UK experience

    Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases – the UK expe... Tekijä Stephanie Sutherland, S. Ashley, David Miles, Stephen Chan, Andrew Wardley, N. Davidson, Rashid Bhatti, Mohamed Shehata, H Nouras, T. Camburn, Stephen Johnston

    Julkaistu 2010
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab

    Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab Tekijä Thomas Yau, Charles Swanton, Sue Chua, Ashley Sue, Geraldine Walsh, A.Y. Rostom, Stephen Johnston, Mary O’Brien, Ian E. Smith

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Molecular Changes in Tamoxifen-Resistant Breast Cancer: Relationship Between Estrogen Receptor, HER-2, and p38 Mitogen-Activated Protein Kinase

    Molecular Changes in Tamoxifen-Resistant Breast Cancer: Relationship Between Estrogen Receptor, HER-2, and p38 Mitogen-Activated Protein Kinase Tekijä Maya Gutierrez, Simone Detre, Stephen Johnston, Syed K. Mohsin, Jiang Shou, D. Craig Allred, Rachel Schiff, C. Kent Osborne, Mitch Dowsett

    Julkaistu 2005
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups

    Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups Tekijä Stephen Johnston, Joyce O’Shaughnessy, Miguel Martín, Jens Huober, Masakazu Toi, Joohyuk Sohn, Valérie André, Holly Martin, Molly Catherine Hardebeck, Matthew P. Goetz

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Imaging in metastatic breast cancer, CT, PET/CT, MRI, WB-DWI, CCA: review and new perspectives

    Imaging in metastatic breast cancer, CT, PET/CT, MRI, WB-DWI, CCA: review and new perspectives Tekijä Dione Lother, Marie Robert, Elliot Elwood, Sam Smith, Nina Tunariu, Stephen Johnston, Marina Parton, Basrull Bhaludin, Thomas P. Millard, Kate Downey, Bhupinder Sharma

    Julkaistu 2023
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II study

    Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009,... Tekijä Bella Kaufman, Maureen Trudeau, Ahmad Awada, Kimberly Blackwell, Thomas Bachelot, Vanessa Salazar, Michelle DeSilvio, Ronald Westlund, Tal Zaks, Neil L. Spector, Stephen Johnston

    Julkaistu 2009
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy

    Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy Tekijä Amna Sheri, Ian E. Smith, Stephen Johnston, Roger A’Hern, Ashutosh Nerurkar, Robin L. Jones, Margaret Hills, Simone Detre, Sarah E. Pinder, W. Fraser Symmans, Mitch Dowsett

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Prognostic Value of Intrinsic Subtypes in Hormone Receptor–Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib

    Prognostic Value of Intrinsic Subtypes in Hormone Receptor–Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib Tekijä Aleix Prat, Maggie C.U. Cheang, Patricia Galván, Paolo Nucíforo, Laia Paré, Bárbara Adamo, Montserrat Muñoz, Margarida Viladot, Michael F. Press, Robert Gagnon, Catherine Ellis, Stephen Johnston

    Julkaistu 2016
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Health-Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2− Advanced Breast Cancer

    Health-Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2− Advanced Breast Cancer Tekijä Matthew P. Goetz, Miguel Martín, Eriko Tokunaga, In Hae Park, Jens Huober, Masakazu Toi, C. Stoffregen, Sarah Shekarriz, Valérie André, M. Corona Gainford, Gregory L. Price, Stephen Johnston

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: